This research aims to characterize the nationwide epidemiology of systemic amyloidosis in Japan, focusing on geographical disparities.
Nationwide registry analysis conducted from 2015 to 2024.
Evaluation of detection and certification rates across different regions in Japan.
Identification of significant geographical variations in the detection of systemic amyloidosis.
Findings suggest potential disparities in healthcare access and diagnosis availability across regions.
Abstract
Background: Systemic amyloidosis has long been considered a rare disease, yet its nationwide epidemiology in Japan remains incompletely characterized, particularly with respect to geographical variation.